M4MM
Leafwell Brings Medical Cannabis to the Benefits Table
CHICAGO – When Emily Fisher, the CEO and founder of virtual Cannabis-based care clinic Leafwell, was navigating her first breast cancer diagnosis, she turned to Cannabis out of desperation, not conviction. There was no physician ...
Cannabis 3.0: Why the Next Phase of the Industry Will Be Built on Platforms, Not Products
NEW YORK- The Cannabis industry is entering a new phase of development. The first phase of the legal Cannabis market was defined by access. Cannabis 1.0 was about legalization, licensing, compliance, and the basic right ...
What’s in a Jar? For Cannabis Concentrate Brands, Quite a Lot
LOS ANGELES – The packaging debate in Cannabis manufacturing rarely makes headlines. But the choice between glass and plastic for concentrate products is one that shapes what a brand becomes and what it can prove. ...
Cannabis 3.0: Why the Next Phase of the Industry Will Be Built on Platforms, Not Products
NEW YORK- The Cannabis industry is entering a new phase of development. The first phase of the legal Cannabis market was defined by access. Cannabis 1.0 was about legalization, licensing, compliance, and the basic right ...
What’s in a Jar? For Cannabis Concentrate Brands, Quite a Lot
LOS ANGELES – The packaging debate in Cannabis manufacturing rarely makes headlines. But the choice between glass and plastic for concentrate products is one that shapes what a brand becomes and what it can prove. ...
UK Medical Cannabis H1 2025: The Market Still Running on Trust
LONDON – You won't find the echoes of this revolution in the National Health Service (NHS) waiting lists or General Practitioner (GP) surgeries. It lives instead in a constellation of private clinics spread across the ...
Virginia Cannabis Licenses Delayed Again After Spanberger Veto
RICHMOND-Virginia’s long-delayed adult-use Cannabis market has suffered another major setback after Governor Abigail Spanberger vetoed legislation that would have created a regulated retail sales framework for the Commonwealth. The veto means Virginia will remain in ...
Leafwell Brings Medical Cannabis to the Benefits Table
CHICAGO – When Emily Fisher, the CEO and founder of virtual Cannabis-based care clinic Leafwell, was navigating her first breast cancer diagnosis, she turned to Cannabis out of desperation, not conviction. There was no physician ...
Cannabis 3.0: Why the Next Phase of the Industry Will Be Built on Platforms, Not Products
NEW YORK- The Cannabis industry is entering a new phase of development. The first phase of the legal Cannabis market was defined by access. Cannabis 1.0 was about legalization, licensing, compliance, and the basic right ...
What’s in a Jar? For Cannabis Concentrate Brands, Quite a Lot
LOS ANGELES – The packaging debate in Cannabis manufacturing rarely makes headlines. But the choice between glass and plastic for concentrate products is one that shapes what a brand becomes and what it can prove. ...
Bioxyne Double-Strikes in LATAM and Europe
SYDNEY – Bioxyne Limited, an international health and life sciences company focused on the manufacturing and distribution of novel medicines, including medical Cannabis, psilocybin, and MDMA, has signed two new commercial agreements – one stretching ...
Rubicon Organics Reports Q1 2026 Financial Results
VANCOUVER – Rubicon Organics Inc. delivered its first-quarter report, revealing results that show both progress and short-term pressures common in an industry shifting toward larger-scale operations – all while balancing strong market share gains with ...
BREAKING: Colorado Passes Landmark Ibogaine Research Bill, Expanding the State’s Natural Medicine Framework
DENVER- Colorado has taken another major step in the evolution of regulated psychedelic medicine. The Colorado legislature has passed House Bill 26-1325, a landmark measure that establishes an ibogaine research pilot program within the state’s ...
The DEA Window: The Real Fight Is Over Who Qualifies as Medical Cannabis
WASHINGTON, D.C. - The real significance of the DEA window is not that the Cannabis industry needs another explanation of legalization. Operators, investors, attorneys, and regulators already understand the limits of federal reform. The more ...
Study: Older Americans Are Turning to Cannabis as an Alternative to Pharmaceuticals
NEW YORK - Older Americans are increasingly looking at Cannabis not as a lifestyle product, but as a practical alternative to traditional pharmaceuticals. A new study highlighted by NORML points to a growing trend among ...
Definium Doses First Patient in Second Phase 3 LSD-Based Trial
NEW YORK – Definium Therapeutics Inc. has taken another step forward in its late-stage testing of a psychedelic-derived treatment for major depressive disorder. The company announced that the first participant received a dose in the ...
Glass House Brands Reports Q1 2026 Financial Results
LONG BEACH – Glass House Brands Inc. released its first-quarter earnings for 2026, showing revenue slightly ahead of internal expectations but down from the year-ago period, with profitability pressured by higher costs and soft wholesale ...
Planet 13 Reports Q1 2026 Financial Results
LAS VEGAS – Planet 13 Holdings Inc. released its first-quarter 2026 financials, reflecting the effects of substantial operational changes and declines in top-line figures, yet showcasing margin gains and cost controls as indications of progress ...
MariMed Reports Q1 2026 Financial Results
NORWOOD – MariMed Inc. turned in another quarter of measured progress in a tough Cannabis market. The company, with operations spanning cultivation, production, and retail facilities across multiple states, has reported year-over-year revenue growth and ...
Grown Rogue Reports Q1 2026 Financial Results
MEDFORD – Grown Rogue International Inc. delivered solid top-line gains in the opening months of 2026, underscoring its push into select markets while managing pressures in more established ones. The company, known for its focus ...
Jushi Reports Q1 2026 Financial Results
BOCA RATON – Jushi Holdings Inc. delivered a quarter of steady operational progress while facing ongoing industry pressures. The multi-state operator recorded year-on-year improvements in revenue and profitability metrics, and completed a significant refinancing of ...
iAnthus Reports Q1 2026 Financial Results
NEW YORK-TORONTO – iAnthus Capital Holdings posted its fiscal first-quarter results for 2026, revealing a company focused on operational tweaks while navigating softer sales in a competitive Cannabis market. The multi-state operator, active across retail ...
Organigram Reports Q2 Fiscal 2026 Results
TORONTO – Organigram Global Inc. released its financial results, marking a quarter shaped by shifts in consumer preferences and execution issues in key categories. The Canadian producer, known for holding the top market share position ...
Cannabis 3.0: From Getting High to Getting Clinical
NEW YORK-Cannabis is entering a new phase, and this one is about much more than consumption. For decades, Cannabis was trapped in prohibition and treated mainly as a legal problem. Then came commercialization, when Cannabis ...
Vireo Growth Reports Q1 2026 Financial Results
MINNEAPOLIS – Vireo Growth Inc. released its first-quarter 2026 financial results, highlighting the early effects of an active acquisition strategy that has broadened its operations across several key Cannabis markets. The company, which operates a ...


















































